Office Of Device Evaluation Deputy Director Phillips Departs FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Device Evaluation has yet to reveal whether it will name a new deputy director for science & regulatory policy, following the Feb. 18 departure of device center veteran Phil Phillips
You may also be interested in...
Ex-FDAer Phillips enters consulting ranks
Former ODE Science & Regulatory Policy Deputy Director Phil Phillips joins Becker & Associates Consulting as director of the firm's medical device practice. The Washington, D.C.-based company provides regulatory and marketing support to healthcare firms. Phillips, who joined FDA in 1981, had served as a liaison between ODE and the Office of Science & Engineering Laboratories before leaving in February (1"The Gray Sheet" Feb. 28, 2005, p. 11)...
Ex-FDAer Phillips enters consulting ranks
Former ODE Science & Regulatory Policy Deputy Director Phil Phillips joins Becker & Associates Consulting as director of the firm's medical device practice. The Washington, D.C.-based company provides regulatory and marketing support to healthcare firms. Phillips, who joined FDA in 1981, had served as a liaison between ODE and the Office of Science & Engineering Laboratories before leaving in February (1"The Gray Sheet" Feb. 28, 2005, p. 11)...
FDA Veteran Schultz Ascends To CDRH Director Position: Who Will Lead ODE?
CDRH's new director, Daniel Schultz, MD, says he would be open to hiring an Office of Device Evaluation chief who lacks a medical degree